About 900 individuals with type 1 diabetes in England are testing a life-changing artificial pancreas. The device uses a sensor instead of a finger stick and prevents life-threatening hypoglycaemic episodes, which happen when blood sugar levels drop too low. It continuously monitors the readings, and a pump automatically adjusts the amount of insulin required. However, the hybrid method is not completely automated, as the number of carbohydrates taken during meals must be manually inputted. According to the National Health Service (NHS) in England, this is the world’s first statewide technology test, and it comes 100 years after the first diabetic patient got insulin injections. The pilot program has 875 participants, with a total of 1,000 expected to take part. The results will be reviewed by the National Institute for Health and Care Excellence (NICE), which will decide where the technology should be used more widely.